Correction: Tislelizumab in Chinese patients with advanced solid tumors: an open-label, non-comparative, phase 1/2 study

Subjects

Subjects :

Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282

Details

Language :

English

ISSN :

20511426

Volume :

8

Issue :

2

Database :

Directory of Open Access Journals

Journal :

Journal for ImmunoTherapy of Cancer

Publication Type :

Academic Journal

Accession number :

edsdoj.614b9ae82a1e4906be36384ec1899554

Document Type :

article

Full Text :

https://doi.org/10.1136/jitc-2019-000437corr1